Total submissions: 14
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000171712 | SCV000050732 | likely benign | not provided | 2013-06-24 | criteria provided, single submitter | research | |
Gene |
RCV000123591 | SCV000166930 | benign | not specified | 2013-02-15 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
ARUP Laboratories, |
RCV000624947 | SCV000602460 | benign | Long QT syndrome 11 | 2021-11-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000618431 | SCV000735921 | likely benign | Cardiovascular phenotype | 2018-08-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome Diagnostics Laboratory, |
RCV000624947 | SCV000743169 | likely benign | Long QT syndrome 11 | 2017-03-14 | criteria provided, single submitter | clinical testing | |
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000624947 | SCV000744222 | likely benign | Long QT syndrome 11 | 2016-09-21 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001080217 | SCV000752848 | likely benign | Long QT syndrome | 2024-01-24 | criteria provided, single submitter | clinical testing | |
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, |
RCV000171712 | SCV000987596 | likely benign | not provided | criteria provided, single submitter | clinical testing | ||
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000123591 | SCV001337794 | benign | not specified | 2020-01-20 | criteria provided, single submitter | clinical testing | Variant summary: AKAP9 c.80C>T (p.Ser27Leu) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.0017 in 249848 control chromosomes in the gnomAD database, including 2 homozygotes. The observed variant frequency is approximately 173 fold of the estimated maximal expected allele frequency for a pathogenic variant in AKAP9 causing Arrhythmia phenotype (1e-05), strongly suggesting that the variant is benign. Five clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as benign/likely benign. Based on the evidence outlined above, the variant was classified as benign. |
Genome- |
RCV000624947 | SCV002524806 | benign | Long QT syndrome 11 | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000171712 | SCV002586177 | benign | not provided | 2024-05-01 | criteria provided, single submitter | clinical testing | AKAP9: BS1, BS2 |
Fulgent Genetics, |
RCV000624947 | SCV002810648 | benign | Long QT syndrome 11 | 2021-08-18 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV000123591 | SCV001925921 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000123591 | SCV001952253 | benign | not specified | no assertion criteria provided | clinical testing |